Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accumold is a privately held U.S. precision micro molding company that designs, tools, molds, validates, and manufactures extremely small thermoplastic components with micron-level features and tight tolerances. The company serves multiple end markets including medical devices, micro electronics, polymer optics/photonics, automotive electronics, and emerging technology, with medical micro molding representing a significant healthcare-facing business line. Accumold operates as a fully integrated in-house manufacturing platform, with tooling, molding, packaging, and metrology performed on its Iowa campus. In healthcare, it supports OEMs developing miniaturized components for applications such as implantable cardiac devices, neurostimulation leads, drug-delivery micro-needle arrays, OCT imaging systems, ophthalmic surgery tools, and other precision medical device assemblies. Rather than developing therapeutics, Accumold commercializes advanced manufacturing capabilities and specialty processes such as insert molding, 2-shot molding, micro structures, polymer optics, and micro additive manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accumold.